Scarica l'app Stockscreener
0.5139
2.15%
0.0108
Dopo l'orario di chiusura:
.51
-0.0039
-0.76%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$0.5031
Aprire:
$0.5
Volume 24 ore:
927.75K
Relative Volume:
0.58
Capitalizzazione di mercato:
$76.53M
Reddito:
$15.93M
Utile/perdita netta:
$-64.59M
Rapporto P/E:
-0.6852
EPS:
-0.75
Flusso di cassa netto:
$-59.50M
1 W Prestazione:
-1.57%
1M Prestazione:
-2.21%
6M Prestazione:
-11.94%
1 anno Prestazione:
-65.04%
Intervallo 1D:
$0.4965
$0.5157
Intervallo di 1 settimana:
$0.495
$0.5434
Portata 52W:
$0.45
$1.50
Veru Inc Stock (VERU) Company Profile
Nome
Veru Inc
Settore
Industria
Telefono
(312) 595-9123
Indirizzo
2916 N. MIAMI AVENUE, MIAMI, FL
Confronta VERU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VERU
Veru Inc
|
0.5139 | 76.53M | 15.93M | -64.59M | -59.50M | -0.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.38 | 110.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.99 | 59.13B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
561.75 | 34.75B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
283.40 | 33.69B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
225.77 | 25.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Veru Inc Stock (VERU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-14 | Iniziato | B. Riley Securities | Buy |
| 2024-03-28 | Iniziato | Raymond James | Outperform |
| 2023-06-07 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-04-13 | Iniziato | Jefferies | Buy |
| 2021-02-09 | Reiterato | H.C. Wainwright | Buy |
| 2020-01-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-03-20 | Iniziato | Oppenheimer | Outperform |
| 2018-07-03 | Iniziato | Maxim Group | Buy |
Mostra tutto
Veru Inc Borsa (VERU) Ultime notizie
Veru signals Q3 2025 regulatory clarity for enobosarm Phase 3 trial - MSN
Barclays PLC Acquires 21,738 Shares of Veru Inc. (NASDAQ:VERU) - Defense World
Veru Inc. (NASDAQ:VERU) Stake Raised by Wells Fargo & Company MN - Defense World
Veru (NASDAQ:VERU) Issues Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Veru Inc. (NASDAQ:VERU) Q2 2025 Earnings Call Transcript - Insider Monkey
Veru Inc. Reports Progress in Clinical Trials and Financials - TipRanks
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... - Yahoo Finance
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial ... By GuruFocus - Investing.com Canada
Veru Inc (VERU) Q2 2025 Earnings Call Highlights: Promising Clinical Results Amid Financial Challenges - GuruFocus
Earnings call transcript: Veru Inc. beats Q2 2025 EPS forecast, stock rises - Investing.com India
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress - GlobeNewswire
Veru Q2 2025 Earnings Call Transcript - MarketBeat
Veru Inc. (VERU) Advances Obesity Program with Promising Trial Results - GuruFocus
VERU INC. SEC 10-Q Report - TradingView
Veru Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Veru Participates in a Virtual Investor KOL Connect Segment | VERU Stock News - GuruFocus
JTC Team Hosts Virtual Investor “KOL Connect” Segment to Discuss Veru Inc.’s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Sacramento Bee
JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s (NASDAQ:VERU) Enobosarm Taking GLP-1 Weight Loss to Next Level - Mid Florida Newspapers
Veru Participates in a Virtual Investor KOL Connect Segment - GlobeNewswire
2 Beaten-Down Stocks That Are Great Buys on the Dip - The Globe and Mail
Veru Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
Veru Inc (VERU) Reports Q2 Fiscal 2025 EPS of -$0.05, Beating Estimates of -$0.06; Revenue Focus Remains on Clinical Progress - GuruFocus
Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress | VERU Stock News - GuruFocus
Veru Inc (VERU) Q2 2025 Earnings Report Preview: What To Look For - GuruFocus
Envestnet Asset Management Inc. Buys 75,997 Shares of Veru Inc. (NASDAQ:VERU) - Defense World
Veru (VERU) Projected to Post Earnings on Thursday - MarketBeat
Financial Snapshot: Analyzing Veru Inc (VERU)’s Key Ratio Metrics - DWinneX
Veru Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView
JPMorgan Chase & Co. Has $166,000 Stock Holdings in Veru Inc. (NASDAQ:VERU) - Defense World
Adage Capital Partners GP L.L.C. Sells 5,561,111 Shares of Veru Inc. (NASDAQ:VERU) - MarketBeat
NewEdge Advisors LLC Raises Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World
Check out these key findings about Veru Inc (VERU) - Sete News
Veru Inc (VERU)’s stock price range in the last year - uspostnews.com
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8 - The Manila Times
Veru Inc. to Host Conference Call for Fiscal Q2 2025 Financial Results and Business Update on May 8, 2025 - Nasdaq
B. Riley Securities gives a Buy recommendation for Veru Inc (VERU) - knoxdaily.com
Veru Inc (VERU) Stock: A Comprehensive 52-Week Review - investchronicle.com
Geode Capital Management LLC Increases Stock Position in Veru Inc. (NASDAQ:VERU) - Defense World
ImmunityBio Inc’s Market Journey: Closing Weak at 2.61, Down -2.97 - DWinneX
Trading Day Review: Capri Holdings Ltd (CPRI) Gains Momentum, Closing at 14.87 - DWinneX
Market Momentum: Coherus Biosciences Inc (CHRS) Registers a 1.98 Increase, Closing at 1.03 - DWinneX
Stock Performance Spotlight: Veru Inc (VERU) Ends the Day at 0.54, Down by -2.02 - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces Veru Inc. (VERU) Investigation - ACCESS Newswire
SOBO Shares Experience Surge in Value - knoxdaily.com
Was Veru Inc (VERU)’s session last reading good? - uspostnews.com
Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summi - GuruFocus
Veru Inc Azioni (VERU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):